Table 1 Clinicopathological factors of bladder cancer and associations with DYRK2 expression
Patients (%) | DYRK2 expression | |||
|---|---|---|---|---|
Negative | Positive | P | ||
All patients | 44 | 23 | 21 | |
Age | 0.35 | |||
<70 years | 17 (39 %) | 7 | 11 | |
≥70 years | 27 (61 %) | 16 | 10 | |
Sex | 0.70 | |||
Male | 36 (82 %) | 18 | 18 | |
Female | 8 (18 %) | 5 | 3 | |
Pathological T stage | 0.27 | |||
1 | 14 (32 %) | 5 | 9 | |
2a | 20 (46 %) | 11 | 9 | |
2b | 10 (23 %) | 7 | 3 | |
Histological grade | ||||
Low | 3 (7 %) | 1 | 2 | 0.60 |
High | 41 (93 %) | 22 | 19 | |
Concurrent CIS | 0.23 | |||
Yes | 7 (16 %) | 2 | 5 | |
No | 37 (84 %) | 21 | 16 | |
Lymphovascular invasion | 1.00 | |||
Yes | 3 (7 %) | 2 | 1 | |
No | 41 (93 %) | 21 | 20 | |